| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,878 |
10,220 |
$3.06M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,015 |
14,400 |
$1.72M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,242 |
2,990 |
$945K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,017 |
9,901 |
$351K |
| 86703 |
|
998 |
940 |
$172K |
| 80053 |
Comprehensive metabolic panel |
8,794 |
7,989 |
$108K |
| 87428 |
|
2,960 |
2,831 |
$57K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,442 |
1,319 |
$51K |
| 86592 |
|
1,054 |
978 |
$45K |
| 59025 |
Fetal non-stress test |
308 |
265 |
$33K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,896 |
1,642 |
$32K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
170 |
145 |
$31K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
150 |
138 |
$29K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
150 |
138 |
$27K |
| 71045 |
Radiologic examination, chest; single view |
1,699 |
1,578 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,157 |
1,117 |
$24K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
141 |
117 |
$22K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
169 |
162 |
$20K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
733 |
703 |
$17K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
60 |
54 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
9,691 |
8,379 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
107 |
101 |
$12K |
| 81025 |
|
1,574 |
1,491 |
$10K |
| 81001 |
|
2,668 |
2,478 |
$9K |
| 93976 |
|
91 |
81 |
$8K |
| 86762 |
|
141 |
74 |
$7K |
| 86803 |
|
52 |
38 |
$7K |
| 84484 |
|
1,086 |
802 |
$7K |
| 87340 |
|
98 |
84 |
$7K |
| 82950 |
|
125 |
122 |
$6K |
| 87081 |
|
89 |
86 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
82 |
80 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
706 |
624 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
280 |
264 |
$6K |
| 86900 |
|
194 |
187 |
$5K |
| 86787 |
|
77 |
26 |
$5K |
| 86850 |
|
52 |
52 |
$5K |
| 86901 |
|
195 |
187 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
82 |
80 |
$4K |
| 76801 |
|
43 |
38 |
$4K |
| 0002A |
|
153 |
152 |
$3K |
| 83690 |
|
691 |
638 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,718 |
1,592 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
264 |
226 |
$3K |
| 83021 |
|
25 |
25 |
$3K |
| 0001A |
|
168 |
152 |
$2K |
| 84702 |
|
244 |
200 |
$2K |
| 80061 |
Lipid panel |
126 |
123 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
84 |
83 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
115 |
106 |
$1K |
| 81003 |
|
994 |
926 |
$1K |
| 82105 |
|
13 |
13 |
$1K |
| 83735 |
|
430 |
395 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
676 |
636 |
$856.18 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$824.06 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
365 |
329 |
$807.29 |
| 87210 |
|
32 |
28 |
$534.10 |
| 82553 |
|
43 |
41 |
$277.09 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
69 |
65 |
$260.19 |
| 83880 |
|
49 |
40 |
$224.41 |
| 70450 |
Computed tomography, head or brain; without contrast material |
17 |
13 |
$219.20 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
44 |
40 |
$218.80 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
58 |
29 |
$208.22 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
31 |
29 |
$194.01 |
| 82550 |
|
72 |
68 |
$183.33 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31 |
29 |
$179.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
498 |
444 |
$127.39 |
| 84703 |
|
13 |
13 |
$89.31 |
| 83605 |
|
44 |
38 |
$67.58 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15 |
14 |
$45.02 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
203 |
183 |
$28.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$24.70 |
| 82962 |
|
182 |
96 |
$8.69 |
| J2704 |
Injection, propofol, 10 mg |
116 |
113 |
$1.56 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
80 |
66 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
13 |
13 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
13 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
13 |
$0.00 |